<html>
<head>
<title>FDA approves esketamine nasal spray, the first new major depression drug in more than 30 years – TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">FDA 批准 30 多年来首个新型抗抑郁药——氯胺酮鼻喷剂</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2019/03/05/fda-approves-esketamine-nasal-spray-the-first-new-major-depression-drug-in-more-than-30-years/amp/">https://web.archive.org/web/https://techcrunch.com/2019/03/05/fda-approves-esketamine-nasal-spray-the-first-new-major-depression-drug-in-more-than-30-years/amp/</a></blockquote><div><div class="content">

			
	
		
		

		
<p class="amp-featured-image translated"><amp-img src="https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?w=600" class="attachment-post-thumbnail size-post-thumbnail wp-post-image amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" alt="" srcset="https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg 600w, https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?resize=150,150 150w, https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?resize=300,300 300w, https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?resize=32,32 32w, https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?resize=50,50 50w, https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?resize=64,64 64w, https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?resize=96,96 96w, https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?resize=128,128 128w" layout="intrinsic" i-amphtml-layout="intrinsic"> <i-amphtml-sizer class="i-amphtml-sizer"> <img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/> </i-amphtml-sizer> <noscript> <img src="../Images/37d3427f3d4da862d499d0e6264f942f.png" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" loading="lazy" srcset="https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg 600w, https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?resize=150,150 150w, https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?resize=300,300 300w, https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?resize=32,32 32w, https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?resize=50,50 50w, https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?resize=64,64 64w, https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?resize=96,96 96w, https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?resize=128,128 128w" sizes="(max-width: 600px) 100vw, 600px" data-original-src="https://web.archive.org/web/20220303122802im_/https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg?w=600"/> </noscript> </amp-img></p><p class="translated"><strong>图片来源:</strong> <a href="https://web.archive.org/web/20220303122802/https://www.janssen.com/" target="_blank">让桑</a></p><p class="translated">几十年来抑郁症治疗最重要的里程碑之一，美国美国食品药品监督管理局<a href="https://web.archive.org/web/20220303122802/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm632761.htm">今天</a>宣布，它已经批准了一种含有氯胺酮衍生物——氯胺酮的新药。</p>
<p class="translated">强生公司生产的商品名为<a href="https://web.archive.org/web/20220303122802/https://www.spravato.com/"> Spravato </a>的药物，本应<a href="https://web.archive.org/web/20220303122802/http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/SPRAVATO-pi.pdf">作为鼻腔喷雾剂</a>与口服抗抑郁药联合使用，针对对其他治疗无反应的患者。Spravato 是自 30 多年前上市的百忧解(Prozac)以来，FDA 批准的第一个主要的新抑郁症治疗方法，百忧解的副作用比旧的抗抑郁药物更少<a href="https://web.archive.org/web/20220303122802/https://www.nytimes.com/2012/04/22/magazine/the-science-and-history-of-treating-depression.html"/>，特别值得注意的是，它被认为比其他药物起效更快。</p>
<p class="translated">这是 FDA 第一次批准氯胺酮用于任何用途(它在 1970 年批准氯胺酮作为麻醉剂)。尽管氯胺酮被认为是一种娱乐性药物，但医生多年来一直在适应症外给抗抑郁药和其他治疗无效的患者开处方。FDA 的顾问委员会上个月以 14 票对 2 票(1 票弃权)通过了该法案。</p>
<p class="translated">FDA 批准了 es 氯胺酮，但警告称，Spravato 只能通过<a href="https://web.archive.org/web/20220303122802/https://www.fda.gov/Drugs/DrugSafety/REMS/ucm592636.htm"> REMS(风险评估和缓解策略)</a>获得，这是其针对具有重大安全问题的药物的受限分销系统，理由是存在镇静和离解的风险，以及滥用和误用的可能性。患者自己使用鼻喷剂，但他们只能在医生的办公室或诊所里使用，并且不能将 Spravato 带回家。</p>
<p class="translated">在三个短期临床试验和一个长期试验中评估了 Spravato 的有效性。其中一项为期四周的短期研究发现，与安慰剂相比，Spravato 和口服抗抑郁药的组合表现出“统计学显著效果”，有时在两天内(其他两项短期试验没有达到预定的有效性统计测试)。</p>
<p class="translated">在更长的试验中，已经稳定并继续使用药物组合的患者比接受安慰剂鼻腔喷雾和口服抗抑郁药物的患者需要“统计学上显著更长的时间”才能复发。</p>


		

			
	
		

			<amp-pixel src="https://web.archive.org/web/20220303122802im_/https://ampmetrics.techcrunch.com/pixel.gif" placeholder="" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
		<amp-analytics data-credentials="include" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed">
		
	</amp-analytics>
		<amp-pixel src="https://web.archive.org/web/20220303122802im_/https://pixel.wp.com/g.gif?v=ext&amp;j=1%3A10.6&amp;blog=136296444&amp;post=1792602&amp;tz=-8&amp;srv=techcrunch.com&amp;host=techcrunch.com&amp;rand=RANDOM&amp;ref=DOCUMENT_REFERRER" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
	<amp-analytics id="parsely" type="parsely" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_googleanalytics" type="googleanalytics" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_comscore" type="comscore" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_parsely" type="parsely" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>	</div>

</div>    
</body>
</html>